-
Most Popular
Search Results
240 results for fsa
NTRB Stock: 11 Things for Nutriband Investors to Know About the Covid-19 Antibody Indicator Patch
Nutriband (NTRB) stock is taking off on Tuesday thanks to news that it will be producing Covid-19 antibody check patches.
Health Care Companies Slow On the Social-Media Draw
Businesses are too worried about FDA pushback.
TSLA Stock: What Really Matters About the Full Self-Driving Rollout
Viral online videos demonstrate how bad Tesla’s FSD software is. If FSD tarnishes Tesla’s reputation, it could be bad news for TSLA stock.
Still Acting Like SPAC, Rocket Lab USA ‘Pops on News, Flops on Booze’
Although RKLB stock is a scientifically intriguing idea, Rocket Lab USA’s market performance is reminiscent of other SPACs, which isn’t encouraging.
Time Is Running Out on Inovio as Other Vaccine Candidates Advance
The FDA’s latest decision has dealt a killer blow to INO stock, which was already struggling to keep up with Big Pharma in the vaccine…
The FAA Just Cleared BP’s Commercial Drone for Takeoff
FAA’s approval of the first commercial drone over land is a watershed moment for the burgeoning industry. Here are 3 pros and 3 cons for…
Flying the Murky Skies of FAA Electronic-Device Restrictions
A wireless specialist says the FAA’s “gadgets-off” rule for passenger planes is based on obsolete wireless technology. But aviation experts still have concerns.
Hostess Brands, Inc. Recall: Which Snack Cakes, Donuts Have Peanut Risk?
Hostess has announced a recall of 710,000 cases of its snack cakes due to them containing undeclared peanut residue from the flour.
Is Fisker (FSR) Stock on the Brink of Death?
Fisker could be among the latest casualties of a fast-declining EV market, with shares seeing their value drop to all-time lows.
Try and Keep Up With Murphy USA
MUSA shares are up over 90% since going public, and with a clear growth strategy in place, there’s no signs of Murphy USA slowing down.
2 ‘Born in the USA’ Industrials to Buy
Think American manufacturing is doomed? Think again. These two “old line” industrials are poised for hefty gains.
Trade of the Day: Public Storage (PSA)
PSA is a solid fundamental performer that could run back up to its highs if the breakout is confirmed.
Trade of the Day: Gerdau USA (GGB)
This mining stock is rebounding quite nicely from a period of trading sideways.
FAA Eases Smartphone and Tablet Regulations
Soon, there will be no need to unplug, ever. And that’s great news for airlines that make a lot of money from in-flight Wi-Fi.
FDA Pulls Approval for a Generic Antidepressant
A generic version of antidepressant Wellbutrin has lost FDA approval after tests showed it less effective than the brand name drug at a certain dosage.
More Products Being ‘Made in USA’
According to a new survey, about two-thirds of American businesses have moved their plants to other locations during the past two years. Many moved to…
Biotech Somaxon Soars on FDA Approval
Somaxon Pharmaceuticals Inc. (SOMX) soared last week after the FDA approved its Silenor as the only treatment of insomnia treatment that was not accompanied by…
Generic Versions of Boniva Approved By the FDA
The FDA approved the first generic versions of osteoporosis drug Boniva, allowing manufacturers like Apotex, Orchid Healthcare and Mylan to make the drug.
Will Apple Get a ‘Made in the USA’ Boost?
It’s official: Apple is indeed moving the manufacturing of one of its Mac lines back to the U.S. The question, of course, is what that…
Is Apple Prepping a ‘Made in USA’ Boom?
It could hinge on whether it picks Intel to make more chip for it — especially for mobile devices. That would be a boon to…
Why Snap Inc (SNAP), Goldcorp Inc. (USA) (GG) and Banco Santander Brasil SA (ADR) (BSBR) Are 3 of Today’s Worst Stocks
Banco Santander Brasil (BSBR), Snap Inc (SNAP) and Goldcorp (GG) couldn’t get on board Tuesday’s bullish bandwagon. Here’s the deal.
Amgen (AMGN) Holds Up Despite FDA Delay
Amgen (AMGN) got news of an FDA delay today on approval of its Prolia drug. Even so, the stock held up fairly well in trading…
Ocugen Latest News: What OCGN Stock Investors Need to Know About the FDA’s Covaxin Rejection
Ocugen (OCGN) stock is falling hard on Friday after the FDA rejected its Emergency Use Authorization request for Covaxin.
3 Takeaways from Amazon’s Bid to Begin U.S. Drone Tests
Amazon’s petition to the FAA is another bold stroke by innovation czar Jeff Bezos. But don’t expect drones to take to the skies soon.
5 – 10 of 240 results
